RayThera, Inc. raised $110 million in Series A financing. The funding will advance their preclinical immunology pipeline and was co-led by Foresite Capital and OrbiMed Advisors.
Amount Raised
$110 Million
Round Type
Series A
San DiegoBiotechnologyPharmaceuticalInvestors
Description
RayThera, Inc., a recently founded biotechnology company focused on small molecule therapies in immunology, has completed its Series A financing with a total of $110 million raised. The financing was co-led by Foresite Capital and OrbiMed Advisors, with participation from TTM Capital. Proceeds will be used to advance RayThera’s lead drug candidates through Phase 1 clinical studies. The strong support from investors is instrumental for the company’s growth.
Quick answer
RayThera raised $110 Million in a Series A round, dated April 4, 2025. Investors: Foresite Capital, Orbimed Advisors and TTM Capital. RayThera is based in San Diego, California, United States.
- How much did RayThera raise?
- RayThera raised $110 Million in a Series A round on April 4, 2025.
- Who invested in RayThera?
- Foresite Capital, Orbimed Advisors and TTM Capital are named as investors in this round.
- What does RayThera do?
- RayThera, Inc. is a small molecule drug discovery company focused on building an immunology pipeline.
- Where is RayThera based and how big is it?
- RayThera is based in San Diego, California, United States. Fundz records about 7 employees.
- Who are the decision-makers at RayThera?
- Fundz holds 1 contact at RayThera. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Pharmaceutical and Biotechnology around the same time
Companies in the same sectors as RayThera that raised within 45 days of this round, from Fundz verified event records.
- Persist AI raised $12M (Series A) on May 19, 2025.
- Strategikon Pharma raised $2.3M (Seed) on May 8, 2025.
- i'SUPPLY raised $3M (Seed) on May 6, 2025.
- Paradigm Therapeutics raised $13M (Funding Round) on May 6, 2025.
- Ousia Pharma raised an undisclosed amount (Seed) on May 6, 2025.
- Azora Therapeutics, Inc. (DE) raised $4.8M on May 2, 2025.
Who to call at RayThera, and when
A new round usually means RayThera is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day RayThera raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at RayThera, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at RayThera. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment RayThera raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansRayThera raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.